MacKay-Dunn R. Hector

Average Profitability
16.06%
Insider Buys Quantity
3
Insider Buys Sum
$156,043.00
Insider Sells Quantity
2
Insider Sells Sum
$86,566.88

Insider Activity of MacKay-Dunn R. Hector

According to the SEC Form 4 filings, MacKay-Dunn R. Hector, being in a position of

  1. director at Aurinia Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5630 shares for $32,316,
    over all time since 2021-05-11, has bought 14000 shares for $156,043, and sold 10448 shares for $86,567.

The largest purchase of all time was on 2021-05-12 and amounted to 6000 shares of Aurinia Pharmaceuticals Inc. for $67,608.

The largest sale of all time was on 2023-05-23 and amounted to 4818 shares of Aurinia Pharmaceuticals Inc. for $54,251.

Biography of MacKay-Dunn R. Hector

No biography is available at this moment.

2024-05-21SaleAurinia Pharmaceuticals Inc.
AUPH
director
5,630
0.004%
$5.74$32,316+23.3%
2023-05-23SaleAurinia Pharmaceuticals Inc.
AUPH
director
4,818
0.0034%
$11.26$54,251-27.72%
2022-03-09PurchaseAurinia Pharmaceuticals Inc.
AUPH
5,000
0.0034%
$11.00$54,985-26.25%
2021-05-12PurchaseAurinia Pharmaceuticals Inc.
AUPH
director
6,000
0.0047%
$11.27$67,608+36.85%
2021-05-11PurchaseAurinia Pharmaceuticals Inc.
AUPH
director
3,000
0.0023%
$11.15$33,450+37.58%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.